Log in

Start Your Membership Now

On December 16, 2021, Pear Therapeutics announced that it has acquired two prescription digital therapeutic (PDT) assets that are designed for the treatment of a “spectrum of depression conditions.” One PDT was acquired from Waypoint Health Innovations, LLC. The second is from a researcher named Fredrik Holländare of Örebro University. Pear intends to incorporate both assets into Pear’s depression platform. However, no timeline for this development has been announced.

The asset acquired from Waypoint Health Innovations is a digital therapeutic designed for treatment of depression based on structured and proven cognitive behavioral therapy (CBT) techniques. The Waypoint asset . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
Log In
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member
If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

Tagged As: